Medical University of South Carolina/Hollings Cancer Center — Charleston, South Carolina

Medical University of South Carolina/Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina/Hollings Cancer Center has participated in 7 clinical trials.

Therapeutic areas: Non-Hodgkin Lymphoma, DLBCL, Diffuse Large B-cell Lymphoma.

Sponsors: Seagen Inc., Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina/Hollings Cancer Center?

Medical University of South Carolina/Hollings Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina/Hollings Cancer Center conducted?

Medical University of South Carolina/Hollings Cancer Center has 7 clinical trials on record. Their work covers Non-Hodgkin Lymphoma, DLBCL, Diffuse Large B-cell Lymphoma.

Is Medical University of South Carolina/Hollings Cancer Center accredited by Crixeo Health?

Yes — Medical University of South Carolina/Hollings Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Medical University of South Carolina/Hollings Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.